Sponsor Dossier
Pharmacor
Sponsor Dossier for Pharmacor. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADENUBEX
- Brand: AKM
- Brand: AKM-ATORVASTATIN
- Brand: AKM-EZETIMIBE
- Brand: AKM-OLMESARTAN HCTZ
- Brand: AKM-PREGABALIN
- Brand: AL-Cefuroxime
- Brand: ALCEPT
- Device (sponsor): Earwax softening otic solution
About
Pharmacor is an Australian Private Company with ABN 58 121 020 835, registered in New South Wales. The entity is active and GST-registered.
Portfolio
Pharmacor has 127 brands on the ARTG, of which 113 are indexable. The company has 111 brands with Product Information on file, 9 brands with at least one PBS-listed item, 6 brands with PBAC outcomes on record, and 1 brand with an AusPAR on record.
Therapeutic focus
— Neurology: 23 brands — Cardiology: 22 brands — Infectious Disease: 18 brands — Pain & Anaesthesia: 13 brands — Immunology: 11 brands — Endocrinology: 10 brands — Urology: 6 brands — Respiratory: 4 brands — Pain Management: 3 brands — Dermatology: 3 brands — Haematology: 3 brands — Gastroenterology: 3 brands — Psychiatry: 2 brands — Oncology: 2 brands — Complementary Medicine: 2 brands — Ophthalmology: 1 brand — Other: 1 brand
PBS footprint
Pharmacor has 9 brands with at least one PBS-listed item, with the latest PBS schedule date their portfolio touched being 2026-05-01.
Regulatory activity
The company's latest PBAC outcome was 2025-07-01, with 6 brands holding PBAC outcomes on record. The latest AusPAR was 2025-01-31, with 1 brand holding an AusPAR on record.